Topical treatment with 5% imiquimod for solitary keratoacanthoma

Yong Ju Kim, Eul Sang Hwang, Sang Wook Son, Il-Hwan Kim

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Keratoacanthoma is a rapidly growing tumor, histologically resembling squamous cell carcinoma. Although it may regress spontaneously, keratoacanthoma is routinely treated by excision. Here we report the successful therapeutic use of imiquimod 5% cream for the treatment of keratoacanthoma. The patient was 35-year old Korean man with solitary dome-shaped nodule on his nose. On the basis of clinical and histopathological examination, the diagnosis of solitary keratoacanthoma of mature stage was made. The tumor mass fully regressed under topical treatment with imiquimod 5% cream within 38 days. No recurrence occurred during a six months follow up period. Imiquimod can be an effective non-operative therapeutic modality for keratoacanthoma.

Original languageEnglish
Pages (from-to)1321-1324
Number of pages4
JournalKorean Journal of Dermatology
Volume42
Issue number10
Publication statusPublished - 2004 Oct 1

Keywords

  • Imiquimod
  • Keratoacanthoma

ASJC Scopus subject areas

  • Dermatology

Fingerprint Dive into the research topics of 'Topical treatment with 5% imiquimod for solitary keratoacanthoma'. Together they form a unique fingerprint.

  • Cite this